ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Valoctocogene Roxaparvovec BLA Accepted for Priority Review by FDA
March 09, 2020BioMarin Pharmaceutical announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) to the FDA for its investigational AAV5 gene therapy ... -
Deals this week: BioMarin Pharmaceutical, Spectrum Pharmaceuticals, Orient Pharma
August 11, 2017US-based biotechnology company BioMarin Pharmaceutical has announced the completion of an underwritten public offering of senior subordinated convertible notes to raise $450m.
Pharma Sources Insight January 2025
